1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for IMGN:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 1990. Start Trial.
Date Value
February 13, 2024 617.9%
February 12, 2024 617.9%
February 09, 2024 641.8%
February 08, 2024 586.4%
February 07, 2024 519.5%
February 06, 2024 526.5%
February 05, 2024 528.8%
February 02, 2024 494.7%
February 01, 2024 534.1%
January 31, 2024 537.4%
January 30, 2024 551.7%
January 29, 2024 519.4%
January 26, 2024 527.8%
January 25, 2024 515.9%
January 24, 2024 531.7%
January 23, 2024 531.8%
January 22, 2024 532.5%
January 19, 2024 561.9%
January 18, 2024 560.6%
January 17, 2024 557.6%
January 16, 2024 554.1%
January 12, 2024 530.5%
January 11, 2024 551.3%
January 10, 2024 551.2%
January 09, 2024 622.0%
Date Value
January 08, 2024 578.4%
January 05, 2024 573.9%
January 04, 2024 516.3%
January 03, 2024 518.4%
January 02, 2024 498.0%
December 29, 2023 474.6%
December 28, 2023 507.6%
December 27, 2023 556.5%
December 26, 2023 540.6%
December 22, 2023 534.6%
December 21, 2023 530.6%
December 20, 2023 517.8%
December 19, 2023 544.9%
December 18, 2023 489.4%
December 15, 2023 492.6%
December 14, 2023 470.0%
December 13, 2023 485.0%
December 12, 2023 486.0%
December 11, 2023 476.8%
December 08, 2023 462.8%
December 07, 2023 463.7%
December 06, 2023 453.6%
December 05, 2023 437.9%
December 04, 2023 434.2%
December 01, 2023 456.4%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
AbbVie, Inc. 23.08%
Pfizer Inc. 14.75%
Johnson & Johnson 56.49%
Merck & Co., Inc. 56.24%
Cerevel Therapeutics Holdings Inc (DELISTED) 46.69%